SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-005827
Filing Date
2022-05-27
Accepted
2022-05-27 17:00:45
Documents
1
Period of Report
2022-05-26

Document Format Files

Seq Description Document Type Size
1 form4-05272022_050513.html 4  
1 form4-05272022_050513.xml 4 3931
  Complete submission text file 0001415889-22-005827.txt   5283
Mailing Address C/O BIOVERATIV INC. 225 SECOND AVENUE WALTHAM MA 02451
Business Address
Cox John (Reporting) CIK: 0001498428 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39746 | Film No.: 22978674

Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Issuer) CIK: 0001821323 (see all company filings)

IRS No.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences